Newsbenzinga
What's Going On With Summit Therapeutics Stock On Monday?
· Published
Article summary
Summit Therapeutics' new ivonescimab trial results showed a survival benefit in lung cancer and encouraging data in colorectal cancer.
An excerpt from the original article.
Comments —
Loading comments…